About this product

Product Identifiers

PublisherNOVA Science Publishers, Incorporated

ISBN-10163463702X

ISBN-139781634637022

eBay Product ID (ePID)13038396538

Product Key Features

Book TitleACE Inhibitors : Medical Uses, Mechanisms of Action, Potential Adverse Effects and Related Topics. Volume 2

Number of Pages373 Pages

LanguageEnglish

TopicLife Sciences / Biochemistry

Publication Year2015

IllustratorYes

GenreScience

AuthorMacaulay Amechi Onuigbo, Macaulay Amechi Chuka Onuigbo

Book SeriesPharmacology-Research, Safety Testing and Regulation Ser.

FormatHardcover

Dimensions

Item Weight24.5 Oz

Item Length10.2 in

Item Width7.1 in

Additional Product Features

Dewey Edition23

Dewey Decimal616.1061

Table Of ContentForeword; Preface; Chronotherapy of Hypertension with ACEIs & CKD: A New Solution to an Old Problem; ACEIs as Antihypertensives in African Americans: A 21st Century Perspective; Angiotensin-Converting Enzyme Inhibitors: A Seattle Internists Perspective; ACEIs in Cardiovascular Medicine: A 21st Century Caribbean Perspective; ACEIs as Antihypertensives: A Nigerian CKD Clinic Experience; ACEIs as Antihypertensives in the Elderly (>65 Year Old): A South American Perspective; The Impact of Salt Restriction on the Effectiveness of Antihypertensive Therapy; Are ARBs the Preferred Agents to Treat Hypertension in Patients with HIV-Nephropathy with Albuminuria?; The Use of ACEIs & ARBs in ESRD Patients on Maintenance Hemodialysis & Peritoneal Dialysis; The Use of Angiotensin-Converting Enzyme Inhibitors in the Renal Transplant Recipient; ACE Inhibition & Renal Artery Stenosis: What Lessons Have we Learnt? A 21st Century Perspective; Angiotensin-Converting Enzyme Inhibitors in Renal Disease: A European Perspective; Angiotensin-Converting Enzyme Inhibitors in Heart Failure; RAAS Blockade in Ethnic Minorities with Chronic Kidney Disease: A United Kingdom Perspective; Use of ACE Inhibitors & Angiotensin-2 Receptor Blockers in the Management of the Cardio-Renal Syndrome; A Three-Year Clinical Experience with ACE Inhibitors at Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria, Department of Pediatrics, 2010-2012; Is There a Role for ACEIs in the ICU?; The Impact of ACE Inhibition in the Management of Sickle Cell Disease in Nigerian Adults; Hypertension-Misattributed Kidney Disease in African Americans; Treatment of Infantile Hemangioma with An ACE Inhibitor: A Paradigm Shift; Epilogue - Bold Predictions on the Future of Renoprotection: The Way Forward with Multiple Pathway ; Blockers Making a Case For Novel Non-Angiotensin Inhibiting Renoprotective Agents like Corticotropin & Pentoxifylline; Index.

SynopsisThis book, published in two volumes, Volume 1 and Volume 2, respectively, represents the most comprehensive and up-to-date collection of current literature on angiotensin inhibition and related topics in medicine, nephrology and cardiovascular medicine ever compiled. Top experts in the various fields of nephrology, hypertension, cardiovascular medicine, pharmacotherapeutics and related fields from all five continents have contributed essays, original papers, reviews and editorial opinions in this volume. This book has turned out to be the most authoritative reference source on ACEIs, with contributions made by leading experts in their various fields of medicine, from the USA, Europe, including the United Kingdom, South America, Australia-New Zealand, Asia including Japan, and Africa. Critically vital clinical topics are covered in this book by top world-renowned experts in different subspecialties, including classic topics such as the efficacy of ACE inhibition as an antihypertensive among the various ethnicities and races, as written from American, African, Caribbean and European perspectives. This volume should indeed serve as a major literature reference text for physicians in general, internists, researchers, cardiologists and hypertension specialists, and especially the practitioners of the art of nephrology in all the countries around the world. Medical students and various physician training programs should reach for a copy of this volume as a research and teaching tool for many years to come. There is also a place here for research scientists in the pharmaceutical industry to review current and newly emerging indications for angiotensin inhibition and the future of reno-protection.

LC Classification NumberQP609.A53